Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
A 40% ethanolic extract accelerated wound healing by modulating IL-10 and MCP-1 release and increasing collagen synthesis [PMID:37111271].
Inhibiting effects on the elevation of triglyceride and cholesterol were observed in both high and low doses [PMID:8323687].
Ethanol extracts and their partitions demonstrated antiproliferative activity in human oral tumor lines SCC-9, SCC4, and SCC-25 [PMID:36535330].
Exerted significant antiproliferative effects in a dose- and time-dependent manner [PMID:23000169].
A bioactive glass-carbon material (BG-Carb) derived from E. hyemale ashes promoted increased bone formation at 7 days compared to hyaluronan alone [PMID:41212454].
Sécurité et effets indésirables
Synthèse des preuves
Sources PubMed
- 1.PMID: 37111271 (2023) — Horsetail (Equisetum hyemale) Extract Accelerates Wound Healing in Diabetic Rats by Modulating IL-10 and MCP-1 Release and Collagen Synthesis. · Pharmaceuticals (Basel, Switzerland)
- 2.PMID: 36535330 (2023) — New substances of Equisetum hyemale L. extracts and their in vivo antitumoral effect against oral squamous cell carcinoma. · Journal of ethnopharmacology
- 3.PMID: 36303438 (2022) — Heavy metal accumulation efficiency and subsequent of cytogenotoxicity evaluation in the medicinal plant Equisetum hyemale. · Journal of toxicology and environmental health. Part A
- 4.PMID: 41471390 (2025) — Equisetum hyemale L. Extracts: Phytochemistry, Biological Performance, ADMET Profiling, and Toxicity Predictions. · Pharmaceuticals (Basel, Switzerland)
- 5.PMID: 25117054